title: Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study.
abstract: OBJECTIVE
  To evaluate health status and participation restrictions in survivors of childhood extremity sarcomas.
  
  
  METHODS
  Members of the Childhood Cancer Survivor Study cohort with extremity sarcomas who completed questionnaires in 1995, 2003, or 2007 were included.
  
  
  METHODS
  Cohort study of survivors of extremity sarcomas.
  
  
  METHODS
  Childhood extremity sarcoma survivors (N=1094; median age at diagnosis, 13y (range, 0-20y); current age, 33y (range, 10-53y); 49% male; 87.5% white; 75% had lower extremity tumors) who received their diagnosis and treatment between 1970 and 1986.
  
  
  METHODS
  Not applicable.
  
  
  METHODS
  Prevalence rates for poor health status in 6 domains and 5 suboptimal social participation categories were compared by tumor location and treatment exposure with generalized estimating equations adjusted for demographic/personal factors and time/age.
  
  
  RESULTS
  In adjusted models, when compared with upper extremity survivors, lower extremity survivors had an increased risk of activity limitations but a lower risk of not completing college. Compared with those who did not have surgery, those with limb-sparing (LS) and upper extremity amputations (UEAs) were 1.6 times more likely to report functional impairment, while those with an above-the-knee amputation (AKA) were 1.9 times more likely to report functional impairment. Survivors treated with LS were 1.5 times more likely to report activity limitations. Survivors undergoing LS were more likely to report inactivity, incomes <$20,000, unemployment, and no college degree. Those with UEAs more likely reported inactivity, unmarried status, and no college degree. Those with AKA more likely reported no college degree. Treatment with abdominal irradiation was associated with an increased risk of poor mental health, functional impairment, and activity limitation.
  
  
  CONCLUSIONS
  Treatment of lower extremity sarcomas is associated with a 50% increased risk for activity limitations; upper extremity survivors are at a 10% higher risk for not completing college. The type of local control influences health status and participation restrictions. Both of these outcomes decline with age.
authors: Department of Pediatrics, Stanford University & Lucile Packard Children's Hospital, Palo Alto, CA, USA. nmarina@stanford.edu
authors: Neyssa
authors: N
authors: Marina
authors: Melissa M
authors: MM
authors: Hudson
authors: Kendra E
authors: KE
authors: Jones
authors: Daniel A
authors: DA
authors: Mulrooney
authors: Raffi
authors: R
authors: Avedian
authors: Sarah S
authors: SS
authors: Donaldson
authors: Rita
authors: R
authors: Popat
authors: Dee W
authors: DW
authors: West
authors: Paul
authors: P
authors: Fisher
authors: Wendy
authors: W
authors: Leisenring
authors: Marilyn
authors: M
authors: Stovall
authors: Leslie L
authors: LL
authors: Robison
authors: Kirsten K
authors: KK
authors: Ness
mesh_terms: D000203:Activities of Daily Living; D000293:Adolescent; D000328:Adult; D002648:Child; D016001:Confidence Intervals; D005121:Extremities; D005260:Female; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012509:Sarcoma / Q000503:physiopathology*; D011795:Surveys and Questionnaires; D017741:Survivors / Q000706:statistics & numerical data*
references: Cancer. 2001 Aug 15;92(4 Suppl):1013-9
references: 11519028
references: Med Pediatr Oncol. 2002 Apr;38(4):229-39
references: 11920786
references: Arch Phys Med Rehabil. 2006 Dec;87(12):1611-7
references: 17141641
references: J Clin Oncol. 2005 Oct 1;23(28):7143-51
references: 16192598
references: Pediatr Blood Cancer. 2007 Aug;49(2):145-8
references: 16732580
references: J Surg Oncol. 1999 Feb;70(2):109-15
references: 10084654
references: J Pediatr Hematol Oncol. 2005 May;27(5):248-53
references: 15891558
references: Cancer. 1986 May 15;57(10):2070-6
references: 3955515
references: J Clin Oncol. 2009 May 20;27(15):2536-41
references: 19349548
references: N Engl J Med. 1986 Jun 19;314(25):1600-6
references: 3520317
references: Cancer. 1994 Jan 15;73(2):476-82
references: 8293416
references: Psychosomatics. 2001 May-Jun;42(3):241-6
references: 11351113
references: J Bone Joint Surg Am. 1994 May;76(5):649-56
references: 8175811
references: Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):265-74
references: 15337565
references: Eur J Cancer. 1997 Jun;33(7):1061-9
references: 9376188
references: Disabil Rehabil. 2006 Jan 15;28(1):61-6
references: 16393834
references: J Natl Cancer Inst. 2010 Aug 18;102(16):1272-83
references: 20656964
references: Orthopedics. 1996 Aug;19(8):657-64
references: 8856775
references: J Clin Oncol. 2009 May 10;27(14):2390-5
references: 19224833
references: Pediatr Blood Cancer. 2008 May;50(5):1032-8
references: 17570705
references: Med Pediatr Oncol. 1999 Oct;33(4):362-71
references: 10491544
references: J Clin Oncol. 2009 Nov 1;27(31):5182-8
references: 19770373
references: J Clin Oncol. 1990 Oct;8(10):1664-74
references: 2213103
references: Br J Cancer. 2004 Sep 13;91(6):1012-4
references: 15292924
references: JAMA. 2003 Sep 24;290(12):1583-92
references: 14506117
references: Cancer. 2011 Feb 1;117(3):625-34
references: 20922787
references: Ann Intern Med. 2005 Nov 1;143(9):639-47
references: 16263886
references: J Clin Oncol. 2002 Feb 1;20(3):776-90
references: 11821461
references: J Clin Oncol. 2004 Dec 15;22(24):4979-90
references: 15576413
references: Radiother Oncol. 1999 Nov;53(2):143-8
references: 10665792
references: Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):763-9
references: 11172960
references: N Engl J Med. 2003 Feb 20;348(8):694-701
references: 12594313
references: J Clin Oncol. 2005 Mar 20;23(9):2004-11
references: 15774791
references: J Clin Oncol. 2009 May 10;27(14):2308-18
references: 19364948
references: Arch Phys Med Rehabil. 1999 Jun;80(6):615-8
references: 10378484
references: J Clin Oncol. 2009 May 10;27(14):2382-9
references: 19332713
references: Sarcoma. 2001;5(1):9-15
references: 18521303
references: Pediatr Clin North Am. 1997 Aug;44(4):1021-42
references: 9286298
references: Pediatr Blood Cancer. 2010 Jul 1;54(7):990-9
references: 20135700
references: Med Pediatr Oncol. 2000 Jun;34(6):413-20
references: 10842248
references: Cancer. 2003 May 15;97(10):2554-64
references: 12733155
references: Clin Orthop Relat Res. 2010 Aug;468(8):2198-210
references: 20033359
references: Curr Treat Options Oncol. 2004 Dec;5(6):477-88
references: 15509481
references: J Clin Oncol. 1985 Oct;3(10):1393-9
references: 4045528
references: Cancer. 1988 Jan 1;61(1):23-32
references: 3334950